Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry refers to a list of closely related signaling proteins: Myostatin, Activin A, Activin B, GDF11, and BMP10. All are members of the transforming growth factor beta (TGF-β) superfamily, participating in related but distinct biological processes. As ligands, they primarily signal through similar receptor complexes, often involving ActRIIB, and are regulated by extracellular antagonists like follistatin. While each is a therapeutic target individually, the combined input is not a single canonical target.
These proteins are ligands that bind to specific type I and type II serine/threonine kinase receptors (primarily activin type II receptors like ActRIIB, and BMP receptors), initiating intracellular SMAD signaling pathways (e.g., SMAD2/3, SMAD1/5/9). Their activity is often modulated by extracellular antagonists such as follistatin and WFIKKN proteins.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myostatin, Activin A, Activin B, GDF11, BMP10.